Literature DB >> 27522158

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.

Thomas J Povsic1, Monica G Lawrence2, A Michael Lincoff3, Roxana Mehran4, Christopher P Rusconi5, Steven L Zelenkofske5, Zhen Huang6, Jeffrey Sailstad7, Paul W Armstrong8, P Gabriel Steg9, Christoph Bode10, Richard C Becker11, John H Alexander6, N Franklin Adkinson12, Arnold I Levinson13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27522158     DOI： 10.1016/j.jaci.2016.04.058

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  55 in total

Review 1.  Watching the gorilla and questioning delivery dogma.

Authors:  Thomas J Anchordoquy; Dmitri Simberg
Journal:  J Control Release       Date:  2017-07-14       Impact factor: 9.776

Review 2.  Advances in environmental and occupational disorders in 2016.

Authors:  William J Sheehan; Jonathan M Gaffin; David B Peden; Robert K Bush; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol       Date:  2017-12       Impact factor: 10.793

3.  Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties.

Authors:  Daniel Y Joh; Zackary Zimmers; Manav Avlani; Jacob T Heggestad; Hakan B Aydin; Nancy Ganson; Shourya Kumar; Cassio M Fontes; Rohan K Achar; Michael S Hershfield; Angus M Hucknall; Ashutosh Chilkoti
Journal:  Adv Healthc Mater       Date:  2019-03-25       Impact factor: 9.933

4.  PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures.

Authors:  Xueguang Lu; Ke Zhang
Journal:  Nano Res       Date:  2018-07-06       Impact factor: 8.897

Review 5.  Therapeutic strategies for thrombosis: new targets and approaches.

Authors:  Nigel Mackman; Wolfgang Bergmeier; George A Stouffer; Jeffrey I Weitz
Journal:  Nat Rev Drug Discov       Date:  2020-03-04       Impact factor: 84.694

6.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

7.  A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

Authors:  Matthew G Fete; Jamie L Betker; Richard K Shoemaker; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2019-01

8.  Sensitive and Quantitative Detection of Anti-Poly(ethylene glycol) (PEG) Antibodies by Methoxy-PEG-Coated Surface Plasmon Resonance Sensors.

Authors:  Peng Zhang; Fang Sun; Hsiang-Chieh Hung; Priyesh Jain; Kasey Joanne Leger; Shaoyi Jiang
Journal:  Anal Chem       Date:  2017-07-24       Impact factor: 6.986

9.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

10.  Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development.

Authors:  Li Xue; Adrienne Clements-Egan; Lakshmi Amaravadi; Mary Birchler; Boris Gorovits; Meina Liang; Heather Myler; Shobha Purushothama; Marta Starcevic Manning; Crystal Sung
Journal:  AAPS J       Date:  2017-11-06       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.